N-Cyclohexylbenzothiazole-2-Sulfenamide from the People's Republic of China: Initiation of Countervailing Duty Investigation

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Commerce International Trade Administration [C-570-235] AGENCY: Enforcement and Compliance, International Trade Administration, Department of Commerce. DATES: Applicable May 27, 2026. FOR FURTHER INFORMATION CONTACT: Kristen Johnson or Samuel Brumitt, Office III, AD/CVD Operations, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482-4793 or (202) 482-7851, respectively. SUPPLEMENTARY INFORMATION: The Petition On May 7, 2026, the U.S. Department of Commerce (Commerce) received a countervailing duty (CVD) petition concerning imports of N-Cyclohexylbenzothiazole-2-Sulfenamide (CBS) from the People's Republic of China (China), filed in proper form on behalf of LANXESS Corporation (the petitioner), a domestic producer of CBS. [ 1 ] The CVD Petition was accompanied by an antidumping duty (AD) petition concerning imports of CBS from China. [ 2 ] Between May 13 and 20, 2026, Commerce requested supplemental information pertaining to certain aspects of the Petition in supplemental questionnaires. [ 3 ] Between May 15 and 21, 2026, the petitioner filed timely responses to these requests for additional information. [ 4 ] In accordance with section 702(b)(1) of the Tariff Act of 1930, as amended (the Act), the petitioner alleges that the Government of China (GOC) is providing countervailable subsidies, within the meaning of sections 701 and 771(5) of the Act, to p…